Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$75.82 - $150.97 $751,982 - $1.5 Million
-9,918 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$132.01 - $190.29 $1.31 Million - $1.89 Million
9,918 New
9,918 $1.46 Million
Q3 2021

Nov 12, 2021

SELL
$132.13 - $177.45 $1.98 Million - $2.66 Million
-15,000 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$144.0 - $179.73 $720,000 - $898,650
5,000 Added 50.0%
15,000 $2.42 Million
Q1 2021

May 12, 2021

BUY
$158.92 - $221.61 $1.59 Million - $2.22 Million
10,000 New
10,000 $1.71 Million

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.